Hva betyr "Tøm"?
Dyret bærer ikke mutasjonen. Det vil ikke utvikle sykdommen og vil ikke gi det videre.
Hund Canine Multiple System Degeneration i Kerry Blue Terrier (CMSD-KBT)
The Canine Multiple System Degeneration (CMSD) DNA test is essential for Kerry Blue Terrier owners to ensure their dogs' health. CMSD is a hereditary neurological disorder affecting coordination and movement in Kerry Blue Terriers. Early genetic testing helps identify carriers and affected dogs, enabling responsible breeding decisions. By using the CMSD DNA test, breeders can reduce the risk of passing this debilitating condition to future generations. This test provides accurate, reliable results, promoting the well-being of your Kerry Blue Terrier. Protect your dog’s health with the CMSD DNA test today. Regular screening supports a healthier, happier canine companion.
Forkortelse: CMSD-KBT
Analysert mutasjon: SERAC1 c.1536G>A
Arv: Autosomal recessiv
Akronym
CMSD-KBT
Observert frekvens
Klinisk alvorlighetsgrad
Klinisk klassifisering
Nevrologiske sykdommer
Analysert mutasjon
SERAC1 c.1536G>A
p.(Trp512*)
p.(Trp512*)
Metode for arv
Autosomal recessiv
Testsammendrag:
Canine Multiple System Degeneration (CMSD) is a genetic disorder affecting Kerry Blue Terriers, causing progressive neurological decline. A DNA test is available to identify carriers and affected dogs, helping breeders make informed decisions. Early detection through testing can prevent the spread of this debilitating condition within the breed. Responsible breeding practices rely on these genetic insights to maintain healthy Kerry Blue Terrier populations. Overall, the CMSD DNA test is a valuable tool for canine health management.
Tilgjengelig fra pakken: Basic
Denne DNA-testen er inkludert fra pakken vår Basic — og er også en del av pakkene Basic, Standard, Advanced, Complete.
Se DNA-testpakker →Velg pakken som passer best til din avl eller helsestrategi for dyrene dine.
Understanding Canine Multiple System Degeneration in Kerry Blue Terriers (CMSD-KBT)
Canine Multiple System Degeneration (CMSD) is a progressive neurological disorder that primarily affects Kerry Blue Terriers. This condition is characterized by the degeneration of multiple systems within the nervous system, leading to a range of debilitating symptoms that can significantly impact the quality of life of affected dogs.
Symptoms of CMSD-KBT
The symptoms of CMSD-KBT typically manifest in early to mid-adulthood, although the age of onset can vary. Common signs include balance problems, difficulty walking, and a general lack of coordination. As the disease progresses, affected dogs may exhibit muscle weakness, tremors, and a decline in overall mobility. In some cases, dogs may also experience changes in behavior, such as increased anxiety or a reluctance to engage in normal activities.
Pathophysiology of CMSD-KBT
The underlying cause of CMSD-KBT lies in genetic mutations that affect the nervous system's ability to function properly. These mutations lead to the degeneration of nerve cells, which in turn causes a breakdown of communication between the brain and the body. This disruption results in the clinical symptoms observed in affected dogs. Understanding the genetic basis of CMSD-KBT is crucial for breeders and owners, as it allows for informed decisions regarding breeding practices and the management of affected animals.
Management and Care for Affected Dogs
While there is currently no cure for CMSD-KBT, management strategies can help improve the quality of life for affected dogs. Regular veterinary check-ups are essential for monitoring the progression of the disease and addressing any health concerns that arise. Physical therapy and rehabilitation exercises can assist in maintaining mobility and strength. Additionally, providing a safe and supportive environment can help dogs cope with their symptoms and enhance their overall well-being.
Konklusjon
Canine Multiple System Degeneration in Kerry Blue Terriers is a serious condition that requires attention from dog owners and breeders. By understanding the symptoms, underlying causes, and management strategies associated with CMSD-KBT, stakeholders can work towards improving the lives of affected dogs while making informed breeding decisions to reduce the prevalence of this condition in the breed.
Rase anerkjent for testen: Canine Multiple System Degeneration i Kerry Blue Terrier (CMSD-KBT)
- Kerry Blue Terrier
🧬 Interpretation of genotypes CMSD-KBT
Genotype
Status
🟡 N/N
Ikke-transportør - Ingen risiko
🟡 N/CMSD-KBT
Transportør - Ingen risiko
❌ CMSD-KBT/CMSD-KBT
Berørt - i faresonen
FAQ: forstå tolkningen
Er en "Carrier" seriøs?
Nei. Dyret er generelt sunt, men kan overføre mutasjonen til dens avkom.
Hva om et dyr er "påvirket"?
Den har to muterte kopier. Kliniske tegn forventes avhengig av sykdommen. Det skal ikke avles.
Hvorfor er det forskjeller mellom mann og kvinne?
Noen sykdommer er kjønnsbundne, så uttrykket deres varierer avhengig av dyrs kjønn.
Forutsi avkom
N/N (ikke-transportor)
N/CMSD-KBT (Transportør)
CMSD-KBT/CMSD-KBT (Berørt)
Vanlige spørsmål om DNA-test
Hva oppdager denne DNA-testen?
This DNA test detects the mutation associated with Canine Multiple System Degeneration In Kerry Blue Terrier (CMSD-KBT) in order to identify clear, carrier, or at-risk animals.
Hvorfor teste et avlsdyr?
DNA-testing hjelper oppdrettere med å planlegge sikrere parringer og redusere risikoen for å overføre mutasjonen til avkom.
Hva er arvemodusen for denne testen?
Arvemodusen som er rapportert for denne testen er autosomal recessiv.
Hvilken mutasjon analyseres i denne testen?
This test analyses the mutation SERAC1 c.1536G>A.
Er et bærerdyr nødvendigvis påvirket?
Ikke nødvendigvis. Tolkning avhenger av arvemønsteret og den resulterende genotypen.
Referanser
Johnson GS, Mhlanga-Mutangadura T, Morava E, Kozicz T, Taylor JF, O’Brien DP, Schnabel RD. Canine Multiple System Degeneration is Associated with Distinct SERAC1 Mutations in Two Different Dog Breeds [abstract]. Presented at the 63rd Annual Meeting of the American Society of Human Genetics in Boston, Massachusetts; 2013 Oct 22-26.